Impact of moderate alcohol consumption on hepatic fibrosis progression in HCV-infected patients

被引：0
|
作者：
Barjoan, E. Marine
Gelsi, E.
Delasalle, P.
Ibragimova, N.
Sattonnet, C.
Saint-Paul, M. C.
Gueyffier, C.
Diebolt, E.
Hayek, R.
Fuzibet, J. G.
Ouzan, D.
Tran, A.
机构：
[1] Univ Hosp, Liver Unit, Nice, France
[2] Univ Hosp, HCV Cote Azur Network, Nice, France
[3] Univ Hosp, Dept Pathol, Nice, France
[4] Gen Hosp, Dept Gastroenterol, Cannes, France
[5] Gen Hosp, Dept Gastroenterol, Menton, France
[6] Univ Hosp, Dept Internal Med, Nice, France
[7] A Tzank Inst, St Laurent Du Var, France
来源：
JOURNAL OF HEPATOLOGY | 2007年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
731
引用
收藏
页码：S275 / S276
页数：2
相关论文
共 50 条
  • [21] Liver fibrosis progression in HIV-HCV coinfected patients is faster than in matched HCV infected patients and is associated with alcohol consumption and CD4 count.
    Benhamou, Y
    Di Martino, V
    Bocher, M
    Charlotte, F
    Azria, F
    Perrin, M
    Vidaud, M
    Opolon, P
    Katlama, C
    Poynard, T
    HEPATOLOGY, 1998, 28 (04) : 564A - 564A
  • [22] Underestimated impact of alcohol consumption on the progression of fibrosis in patients transplanted for HCV-related cirrhosis: A comparative study with patients transplanted for alcohol-related cirrhosis
    Sobesky, R
    Francoz, C
    Boudjema, H
    Paradis, V
    Dondero, F
    Belghiti, J
    Marcellin, P
    Durand, F
    HEPATOLOGY, 2005, 42 (04) : 480A - 480A
  • [23] Alpha v beta 6 integrin is highly upregulated in experimental liver fibrosis and associated with liver fibrosis progression in HCV-infected patients.
    Patsenker, E
    Popov, Y
    Stickel, F
    Mayer, B
    Niedobitek, G
    Schuppan, D
    HEPATOLOGY, 2004, 40 (04) : 543A - 543A
  • [24] Underestimated impact of alcohol consumption on the progression of fibrosis in patients transplanted for HCV-related cirrhosis: A comparative study with patients transplanted for alcohol-related cirrhosis
    Sobesky, R.
    Francoz, C.
    Boudjema, H.
    Paradis, V.
    Dondero, E.
    Belghiti, J.
    Valla, D.
    Marcellin, R.
    Durand, F.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S69 - S69
  • [25] Hepatic fibrosis progression in Indian patients with chronic HCV infection
    Tyagi, Pankaj
    Shakuja, Puja
    Hissar, Sayyed
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A18 - A18
  • [26] FIB-4: A simple, inexpensive and accurate marker of fibrosis in HCV-infected patients
    Vallet-Pichard, Anais
    Mallet, Vincent
    Pol, Stanislas
    HEPATOLOGY, 2006, 44 (03) : 769 - 769
  • [27] Combination of FIB-4 and ELF to evaluate liver fibrosis in HCV-infected patients
    Gabriel Medina, P.
    Gemra Mimun, M.
    Lopez Martinez, R. M.
    Rando Segura, A.
    Rodriguez Frias, F.
    CLINICA CHIMICA ACTA, 2019, 493 : S547 - S547
  • [28] Can we identify liver fibrosis in HCV-infected patients without a liver biopsy?
    Xavier Forns
    Ramón Bataller
    Current Hepatitis Reports, 2003, 2 (4) : 145 - 151
  • [29] CC GENOTYPE OF rs12979860 IL28B MODERATES PROGRESSION OF LIVER FIBROSIS IN HCV-INFECTED PATIENTS
    Frankova, S.
    Bartakova, R.
    Jirsa, M.
    Hejda, V.
    Urbanek, P.
    Merta, D.
    Spicak, J.
    Trunecka, P.
    Sperl, J.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S186 - S186
  • [30] Sustained Virologic Response Predicts Fibrosis Regression Measured by FibroTest in HCV-infected Patients
    Forns, Xavier
    Welzel, Tania M.
    Cohen, Eric
    Jacobson, Ira M.
    Davis, Mitchell
    Reindollar, Robert
    Hu, Bonnie
    Dylla, Douglas E.
    Enejosa, Jeffrey V.
    Trinh, Roger
    Sulkowski, Mark S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S364 - S365
12345